Literature DB >> 18781382

Semiparametric mixed-effects analysis of PK/PD models using differential equations.

Yi Wang1, Kent M Eskridge, Shunpu Zhang.   

Abstract

Motivated by the use of semiparametric nonlinear mixed-effects modeling on longitudinal data, we develop a new semiparametric modeling approach to address potential structural model misspecification for population pharmacokinetic/pharmacodynamic (PK/PD) analysis. Specifically, we use a set of ordinary differential equations (ODEs) with form dx/dt = A(t)x + B(t) where B(t) is a nonparametric function that is estimated using penalized splines. The inclusion of a nonparametric function in the ODEs makes identification of structural model misspecification feasible by quantifying the model uncertainty and provides flexibility for accommodating possible structural model deficiencies. The resulting model will be implemented in a nonlinear mixed-effects modeling setup for population analysis. We illustrate the method with an application to cefamandole data and evaluate its performance through simulations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18781382     DOI: 10.1007/s10928-008-9096-2

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  13 in total

1.  Self-modeling for two-dimensional response curves.

Authors:  W M Ladd; M J Lindstrom
Journal:  Biometrics       Date:  2000-03       Impact factor: 2.571

2.  Estimation and inference for a spline-enhanced population pharmacokinetic model.

Authors:  Lang Li; Morton B Brown; Kyung-Hoon Lee; Suneel Gupta
Journal:  Biometrics       Date:  2002-09       Impact factor: 2.571

3.  Ordinary differential equation PK/PD models using the SAS macro NLINMIX.

Authors:  Andrzej T Galecki; Russell D Wolfinger; Oscar A Linares; Marla J Smith; Jeffrey B Halter
Journal:  J Biopharm Stat       Date:  2004-05       Impact factor: 1.051

4.  Non-linear mixed-effects pharmacokinetic/pharmacodynamic modelling in NLME using differential equations.

Authors:  Christoffer W Tornøe; Henrik Agersø; E Niclas Jonsson; Henrik Madsen; Henrik A Nielsen
Journal:  Comput Methods Programs Biomed       Date:  2004-10       Impact factor: 5.428

5.  A Bayesian approach to tracking patients having changing pharmacokinetic parameters.

Authors:  David S Bayard; Roger W Jelliffe
Journal:  J Pharmacokinet Pharmacodyn       Date:  2004-02       Impact factor: 2.745

Review 6.  Estimating population kinetics.

Authors:  S L Beal; L B Sheiner
Journal:  Crit Rev Biomed Eng       Date:  1982

7.  Pharmacokinetics of cefamandole using a HPLC assay.

Authors:  N S Aziz; J G Gambertoglio; E T Lin; H Grausz; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

8.  Pharmacokinetic/pharmacodynamic modelling of GnRH antagonist degarelix: a comparison of the non-linear mixed-effects programs NONMEM and NLME.

Authors:  Christoffer W Tornøe; Henrik Agersø; Henrik A Nielsen; Henrik Madsen; E Niclas Jonsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2004-12       Impact factor: 2.745

9.  Stochastic differential equations in NONMEM: implementation, application, and comparison with ordinary differential equations.

Authors:  Christoffer W Tornøe; Rune V Overgaard; Henrik Agersø; Henrik A Nielsen; Henrik Madsen; E Niclas Jonsson
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

10.  A population pharmacokinetic model with time-dependent covariates measured with errors.

Authors:  Lang Li; Xihong Lin; Morton B Brown; Suneel Gupta; Kyung-Hoon Lee
Journal:  Biometrics       Date:  2004-06       Impact factor: 2.571

View more
  1 in total

1.  Using spline-enhanced ordinary differential equations for PK/PD model development.

Authors:  Yi Wang; Kent Eskridge; Shunpu Zhang; Dong Wang
Journal:  J Pharmacokinet Pharmacodyn       Date:  2008-11-07       Impact factor: 2.745

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.